Huang P - Search Results

1

Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.

Huang P, Chen J, Wang L, Na Y, Kaku H, Ueki H, Sasaki K, Yamaguchi K, Zhang K, Saika T, Nasu Y, Watanabe M, Kumon H. Huang P, et al. Med Oncol. 2012 Jun;29(2):829-34. doi: 10.1007/s12032-011-9962-4. Epub 2011 May 1. Med Oncol. 2012. PMID: 21533858

2

Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.

Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH, Kumon H. Watanabe M, et al. Among authors: huang p. Int J Oncol. 2009 Mar;34(3):657-63. doi: 10.3892/ijo_00000191. Int J Oncol. 2009. PMID: 19212670

3

REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.

Chen J, Watanabe M, Huang P, Sakaguchi M, Ochiai K, Nasu Y, Ouchida M, Huh NH, Shimizu K, Kashiwakura Y, Kaku H, Kumon H. Chen J, et al. Among authors: huang p. Int J Mol Med. 2009 Dec;24(6):789-94. doi: 10.3892/ijmm_00000293. Int J Mol Med. 2009. PMID: 19885619

4

A comparison of proteomic profiles changes during 17beta-estradiol treatment in human prostate cancer PC-3 cell line.

Chen J, Huang P, Kaku H, Zhang K, Watanabe M, Saika T, Nasu Y, Kumon H. Chen J, et al. Among authors: huang p. Cancer Genomics Proteomics. 2009 Nov-Dec;6(6):331-5. Cancer Genomics Proteomics. 2009. PMID: 20065320 Free article.

5

Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.

Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P, Yamaguchi K, Nasu Y, Kobayashi Y, Sakaguchi M, Ochiai K, Yamada H, Takei K, Ueki H, Huh NH, Li M, Kaku H, Na Y, Kumon H. Zhang K, et al. Among authors: huang p. Int J Oncol. 2010 Dec;37(6):1495-501. doi: 10.3892/ijo_00000802. Int J Oncol. 2010. PMID: 21042718

6

Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging.

Watanabe M, Ueki H, Ochiai K, Huang P, Kobayashi Y, Nasu Y, Sasaki K, Kaku H, Kashiwakura Y, Kumon H. Watanabe M, et al. Among authors: huang p. Oncol Rep. 2011 Oct;26(4):769-75. doi: 10.3892/or.2011.1371. Epub 2011 Jul 1. Oncol Rep. 2011. PMID: 21725614

7

Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.

Ochiai K, Watanabe M, Ueki H, Huang P, Fujii Y, Nasu Y, Noguchi H, Hirata T, Sakaguchi M, Huh NH, Kashiwakura Y, Kaku H, Kumon H. Ochiai K, et al. Among authors: huang p. Biochem Biophys Res Commun. 2011 Aug 26;412(2):391-5. doi: 10.1016/j.bbrc.2011.07.109. Epub 2011 Aug 3. Biochem Biophys Res Commun. 2011. PMID: 21835165 Free article.

8

Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects.

Wang L, Kaku H, Huang P, Xu K, Yang K, Zhang J, Li M, Xie L, Wang X, Sakai A, Watanabe M, Nasu Y, Shimizu K, Kumon H, Na Y. Wang L, et al. Among authors: huang p. Acta Med Okayama. 2011 Oct;65(5):315-23. Acta Med Okayama. 2011. PMID: 22037268 Free article.

9

[REIC/Dkk-3 gene therapy].

Watanabe M, Kaku H, Huang P, Kumon H, Nasu Y. Watanabe M, et al. Among authors: huang p. Nihon Rinsho. 2011 Jun;69 Suppl 5:559-63. Nihon Rinsho. 2011. PMID: 22208044 Japanese. No abstract available.

10

Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.

Kawauchi K, Watanabe M, Kaku H, Huang P, Sasaki K, Sakaguchi M, Ochiai K, Huh NH, Nasu Y, Kumon H. Kawauchi K, et al. Among authors: huang p. Acta Med Okayama. 2012;66(1):7-16. doi: 10.18926/AMO/48076. Acta Med Okayama. 2012. PMID: 22358134 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,851 results

Search Page

Filters